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ORIGINAL ARTICLE
Community-acquired pneumonia (CAP) is one
of the most common childhood diseases world-
wide. The incidence in children aged < 5 years has
been reported as 36–40 episodes/1000 children/
year, and 2.5 million cases occur annually in
Europe.1,2
Streptococcus pneumoniae is thought to be the
main cause of CAP in children,3 and it has been
reported to be the most common etiologic agent
of childhood CAP,4 particularly among children
under the age of 5 years.5,6 It is difficult to diagnose
pneumococcal CAP (PCAP) because few children
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Conclusion: Our results indicate that children hospitalized with PCAP are common in Taiwan. About
20% of these children need ICU admissions, and some still have a poor outcome. Effective immunization
programs with pneumococcal conjugate vaccine are needed for disease control and prevention. [J Formos
Med Assoc 2008;107(12):945–951]
Key Words: bacterial, community acquired pneumonia, epidemiological study, immunization,
Streptococcus pneumoniae
©2008 Elsevier & Formosan Medical Association
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1Division of Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital-Kaohsiung Medical Center,
Chang Gung University College of Medicine, Kaohsiung; 2Division of Infectious Disease, Department of Internal
Medicine, Buddhist Tzu Chi General Hospital, Hualien; 3Division of Pediatric Infectious Diseases, Department of
Pediatrics, Chang Gung Children’s Hospital, Chang Gung University College of Medicine; 4Department of Pediatrics,
China Medical University Hospital, Taichung; 5Department of Pediatrics, National Taiwan University Hospital, Taipei,
Taiwan.
Received: December 17, 2007
Revised: April 10, 2008
Accepted: July 8, 2008
*Correspondence to: Dr Li-Min Huang, Department of Pediatrics, National Taiwan
University Hospital, 7 Chung-Shan South Road, Taipei 100, Taiwan.
E-mail: lmhuang@ntu.edu.tw
†Yi-Chuan Huang and Yu-Huai Ho contributed equally to this work.
with pneumonia have bacteremia, therefore, blood
cultures are often not positive. Unfortunately, no
ideal etiologic diagnostic method that is nonin-
vasive and accurate has yet been developed. Most
diagnoses are based only on the signs, symptoms,
radiologic findings, and results of nonspecific
laboratory tests.7 Better methods for making a
definitive diagnosis of pneumococcal pneumonia
(PP) are required.6,8 Given the lack of accurate
diagnosis, the epidemiology of childhood bacte-
rial pneumonia is not known precisely. Although
most patients with PCAP recover fully, some pa-
tients develop pulmonary complications, such as
atelectasis and empyema.9–11 Streptococcal pneu-
monia is still a major cause of morbidity in young
children.7
The features of childhood CAP vary between
countries and regions of the world. To recognize,
treat and control this infectious disease, addi-
tional information is needed. The purpose of this
study was to determine the epidemiology and
morbidity of PCAP in children hospitalized with
pneumonia in Taiwan. A large-scale survey will
provide data for evaluation that can be used to
determine if additional programs, such as for pre-
vention and vaccination or better screening and
diagnosis, may be indicated for Taiwan. As far as
we know, there has been no comparable study that
includes island-wide, epidemiologic information
about PCAP in Taiwan.
Methods
Study population
A retrospective review of the medical records 
of patients hospitalized with pneumonia, diag-
nosed according to the International Classification
of Diseases, Clinical Modification, 9th Revision (ICD-
9: 481, 483, 486, 510), from January 2000 to
December 2005 was conducted at four hospi-
tals: Kaohsiung Chang-Gung Memorial Hospital
(CGMH-KS), southern Taiwan; National Taiwan
University Hospital (NTUH), northern Taiwan;
China Medical University Hospital (CMUH),
central Taiwan; and Buddhist Tzu Chi General
Hospital (BTCGH), eastern Taiwan. The study was
reviewed by the ethics committees of the four
hospitals. The study population, which consisted
of children with a discharge diagnosis of pneu-
monia, was identified from computer-generated
records. Those defined as suspected PCAP were
recruited based on the following inclusion crite-
ria: (1) pediatric inpatients, aged 3 months to 15
years; and (2) pneumonia, with radiologic signs
of lobar/focal changes on chest X-ray, associated
with fever (with or without cough, consolidation,
acute respiratory failure, gastrointestinal problems,
or other related signs and symptoms).
Study endpoints
The following endpoints were studied: (1) preva-
lence of PCAP; (2) proportion of suspected or
likely/definite cases of PP, as well as their mor-
bidity and mortality; (3) seasonal and annual
distribution of PP cases; and (4) clinical outcomes
of childhood PCAP in Taiwan.
Data collection
Data were collected using computerized hospital
databases. All cases of suspected PCAP were fur-
ther classified as either definite or likely cases of
PCAP, based on radiologic findings, clinical symp-
toms, and specific and nonspecific laboratory
tests. Definite cases were identified by the pres-
ence of lobar or focal consolidation, and at least
one blood or pleural effusion culture that grew
S. pneumoniae, or a positive S. pneumoniae antigen
in the pleural effusion. Likely cases were identi-
fied by the presence of lobar or focal consolida-
tion, negative blood cultures, and white blood
cell count ≥ 20,000/mm3, neutrophils ≥ 10,000/
mm3, C-reactive protein ≥ 60 mg/L, or the pres-
ence of a positive urinary S. pneumoniae antigen
test, or a positive sputum/throat swab culture for
S. pneumoniae.
Statistical analysis
Continuous variables are reported as mean ±
standard deviation; categorical data are presented
as number (n) and percentage. For data that were
not normally distributed, such as duration of
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hospital and intensive care unit (ICU) stay, the
data are presented as median (range). Statistical
analyses were performed using SPSS version 15.0
(SPSS Inc., Chicago, IL, USA).
Results
Proportion of suspected and likely/
definite cases of PP
The enrolled cases were categorized into two types
based on the investigator’s judgment after review-
ing the case reports. There were 2350 children
with PCAP who met the inclusion criteria, were
hospitalized for pneumonia, and had radiologic
findings of lobar or focal consolidation. The likely/
definite PP group consisted of 901 patients (806
patients were likely, and 95 were definite). Figure 1
shows the distribution of patients between 2000
and 2005. In 2000, the frequency of suspected
PCAP increased gradually every year, and peaked
in 2003 (22.14%); while the proportion of likely/
definite PP was highest in 2004 (9.75%). The
likely/definite PP group accounted for 6.98% of
the hospitalized pneumonia patients from 2000
to 2005.
The distribution of patients in the four par-
ticipating hospitals from 2000 to 2005 is shown
in Figure 2. A significantly higher incidence of
suspected PCAP was found at CGMH-KS between
2001 and 2003 (Figure 2A). For cases in the likely/
definite PP group, a higher incidence was observed
at NTUH from 2000 to 2002 (Figure 2B).
Demographic data of suspected and
likely/definite cases of PP
The demographic characteristics and ages of the
affected children in the suspected PCAP and likely/
definite PP groups from 2000 to 2005 are shown
in Table 1. In the suspected PCAP group and the
likely/definite PP group, the mean ages were 4.59
and 4.21 years, respectively, from 2000 to 2005. In
2005, the children were the oldest (PCAP, 5.35 ±
2.93 years; PP, 4.52 ± 2.24 years), and there was
an approximately equal distribution of males and
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Figure 1. Distribution of patients between 2000 and 2005.
Figure 2. Distribution of patients in the four participating hospitals between 2000 and 2005: (A) suspected cases; 
(B) likely/definite cases.
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females. Overall, the children most affected in the
suspected PCAP and likely/definite PP groups were
3–5 years of age (37.9% and 43.6%, respectively).
The clinical syndromes of the suspected PCAP
and likely/definite PP groups are shown in Table
2. From 2000 to 2005 in the suspected PCAP
cases, abdominal syndrome was present in 16.3%
of patients, and respiratory distress syndrome
was present in 15.9%. In the likely/definite PP
group, respiratory distress syndrome was the most
common presentation (21.6%).
Quarterly (seasonal) distribution
Suspected PCAP can be acquired at any time of the
year, although there is a slightly higher incidence
from January to March (Figure 3A). The suspected
case designation was most common between April
and June, both in 2002 (28.7%) and in 2005
(39.4%). A similar distribution was observed in
the likely/definite PP group, with a slightly higher
incidence from January to March (Figure 3B). It was
noted that the third quarter (July to September)
had the lowest incidence of the disease for both
groups.
Duration and clinical outcome
Table 3 shows the lengths of hospital and ICU
stays, and clinical outcomes of the suspected PCAP
and likely/definite PP groups between 2000 and
2005. In the suspected PCAP group, the median
duration of hospital stay was 7 days (range, 1–
385 days); in the likely/definite PP group, the
median duration of hospital stay was also 7 days
(range, 2–94 days). ICU admission was required
in 17.9% of children with suspected PCAP, and
in 21.3% of children in the likely/definite PP
Table 1. Demographic data between 2000 and 2005*
Year
Total
2000 2001 2002 2003 2004 2005
Age (yr)
Suspected cases 4.59 ± 2.85 4.28 ± 2.66 4.35 ± 2.65 4.22 ± 2.69 4.80 ± 3.09 4.31 ± 2.80 5.35 ± 2.93
Likely/definite cases 4.21 ± 2.36 4.20 ± 2.33 4.03 ± 2.21 4.11 ± 2.42 4.15 ± 2.29 4.19 ± 2.61 4.52 ± 2.24
Age stratified
Suspected cases
≤ 1 yr 128 (5.4) 21 (6.5) 23 (6.0) 23 (5.9) 20 (4.7) 23 (6.3) 18 (3.9)
1 < yr ≤ 3 568 (24.2) 90 (28.0) 96 (25.0) 109 (28.2) 100 (23.5) 99 (27.0) 74 (15.9)
3 < yr ≤ 5 891 (37.9) 124 (38.5) 148 (38.5) 158 (40.8) 157 (36.9) 143 (39.1) 161 (34.6)
5 < yr ≤ 15 763 (32.5) 87 (27.0) 117 (30.5) 97 (25.1) 149 (35.0) 101 (27.6) 212 (45.6)
Likely/definite cases
≤ 1 yr 35 (3.9) 7 (5.7) 3 (2.2) 5 (3.3) 8 (5.5) 5 (2.8) 7 (4.3)
1 < yr ≤ 3 238 (26.4) 30 (24.4) 44 (31.7) 44 (28.8) 35 (24.0) 57 (32.4) 28 (17.1)
3 < yr ≤ 5 393 (43.6) 56 (45.5) 57 (41.0) 74 (48.4) 62 (42.5) 69 (39.2) 75 (45.7)
5 < yr ≤ 15 235 (26.1) 30 (24.4) 35 (25.2) 30 (19.6) 41 (28.1) 45 (25.6) 54 (32.9)
Gender (male)
Suspected cases 1195 (50.9) 169 (52.5) 193 (50.3) 197 (50.9) 213 (50. 0) 201 (54.9) 223 (48.0)
Likely/definite cases 443 (49.2) 66 (53.7) 70 (50.4) 75 (49.0) 72 (49.3) 88 (50.0) 73 (44.5)
*Data presented as mean ± standard deviation or n (%).
Table 2. Description of baseline characteristics by
population*
Suspected Likely/
cases definite cases
Temperature (°C) 38.63 ± 1.05 38.68 ± 1.04
Clinical syndrome
Respiratory 374 (15.9) 195 (21.6)
Abdominal 382 (16.3) 185 (20.5)
Otitis 120 (5.1) 54 (6.0)
Asthma 27 (1.1) 13 (1.4)
Meningeal 5 (0.2) 2 (0.2)
*Data presented as mean ± standard deviation or n (%).
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group. The median ICU stay in the suspected
PCAP group was 5 days (range, 1–46 days); in
the likely/definite PP group, the median ICU
stay was 5 days (range, 1–34 days). In both the
suspected PCAP and likely/definite PP groups, the
majority of patients were discharged without se-
quelae. Additionally, in the suspected PCAP group,
14 patients died (0.6%), and five (0.2%) were
discharged with sequelae. In the likely/definite
PP group, nine patients died (1%), and four
(0.4%) were discharged with sequelae.
Discussion
CAP is a major cause of morbidity and mortality
in children and requires aggressive prevention,
diagnosis and management. Diagnosis of CAP is
based on age, history and physical examination,
and the use of chest X-ray and laboratory exami-
nation as indicated. This is believed to be the
first epidemiologic study of PP in children aged
< 15 years in Taiwan. It reports pertinent demo-
graphic factors such as case distribution by age
and sex, and baseline characteristics of a CAP
population, which provides useful information
for future health program planning, and related
studies in this group of patients. The data on PCAP
that requires hospitalization, including ICU stay,
may also be valuable in facilities planning for the
pediatric population.
No gender difference was found in either the
suspected PCAP or the likely/definite PP groups.
Of all cases of hospitalized pneumonia, suspected
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Figure 3. Quarterly distribution of cases between 2000 and 2005: (A) suspected cases; (B) likely/definite cases.
Table 3. Description of hospital stay, intensive care unit (ICU) stay and clinical outcomes by cases*
Suspected cases Likely/definite cases
Hospital stay (d) 7 (1–385) 7 (2–94)
ICU stay (d) 5 (1–46) 5 (1–34)
Number of ICU admissions 420 (17.9) 192 (21.3)
Clinical outcome
Discharge without sequelae 2329 (99.1) 886 (98.3)
Discharge with sequelae 5 (0.2) 4 (0.4)
Discharge but sequelae not identified 1 (0.0) 1 (0.1)
Death 14 (0.6) 9 (1.0)
*Data presented as median (range) or n (%).
PCAP accounted for 18.2%, while the likely/
definite PP group accounted for 6.98%. The inci-
dence of identifying S. pneumoniae in pediatric
pneumonia was low in the present study. This
could perhaps be due to the difficulty of obtaining
diagnostic specimens in children, or because the
discharge diagnosis of pneumonia is loose for a
hospitalized pediatric patient with respiratory tract
infection in most hospitals in Taiwan. Children
from 3 to 5 years of age were the most commonly
affected in the suspected PCAP group (37.9%)
and the likely/definite PP group (43.6%). Most
previous studies5,6,11–14 have shown that children
hospitalized for PP tend to be ≤ 5 years old.3
Young children requiring hospitalization, es-
pecially in the ICU, pose a unique challenge in
hospitals more suited to the adult patient. Our
survey results indicate that: (1) median hospital
stay was 7 days in both groups; (2) rate of ICU
admission ranged from 17.9% in the suspected
PCAP group to 21.3% in the likely/definite PP
group; and (3) median ICU stay was 5 days in
both groups. The mortality rate ranged from 0.6%
in the suspected PCAP group to 1% in the likely/
definite PP group; and 0.2% of the suspected
PCAP group and 0.4% of the likely/definite PP
group were discharged with sequelae. Hospitals
may need to assess services provided to children
and families in relation to inpatient and ICU stays,
and care after discharge.
Drug resistance of S. pneumoniae has been
shown to be closely related to pneumonia in
children.15 The frequency of multidrug-resistant
S. pneumoniae is increasingly common world-
wide.16 For these reasons, a proper prevention pro-
gram against infectious disease is essential and
urgent. The use of pneumococcal vaccine to pre-
vent S. pneumoniae infection seems to be an ideal
way to prevent this disease.
In the present study, there was seasonal varia-
tion in PP incidence, and occurrence was lowest
in the third quarter (July to September) for both
groups. This variance may have been due to the
geographic location of Taiwan as a subtropical
area. Pneumococcal disease usually occurs weeks
after viral infection,17 which is more predominant
in winter. Children are still susceptible to PP re-
gardless of season. High population density may
also play a role in disease transmission.
The present study provides useful informa-
tion about the frequency and severity of PCAP.
Understanding the epidemiology of PCAP may
help to evaluate the potential impact of pneumo-
coccal vaccines, and to plan related prevention
strategies in Taiwan. According to most reported
studies, the evidence indicates that pneumo-
coccal conjugate vaccine has high efficacy. Full
vaccination decreases the incidence of PP and in-
vasive pneumococcal diseases in children.18–20
The pneumococcal conjugate vaccine was intro-
duced island-wide in Taiwan in 2005, after safety
and immunogenicity evaluation.21,22 In order to
achieve the goal of prevention, several factors
should be seriously considered. The impact of
immunization with pneumococcal conjugate vac-
cine on pneumococcal infections at the commu-
nity level still needs to be investigated. In addition,
the community burden of pneumococcal disease
other than PCAP requires evaluation. To increase
the efficiency of pneumococcal vaccines, changes
in the serotype distribution of S. pneumoniae need
to be monitored.
This study had limitations. Since it was retro-
spective, it was limited by an inability to confirm
the etiology of the pneumonia in most patients.
Most diagnoses were based primarily on clinical
judgment, which is insufficient as a trial endpoint.
However, the patients in the likely/definite PP
group had at least one S. pneumoniae-positive
blood, sputum or throat swab culture, or S. pneu-
moniae antigen was identified in pleural effusion.
We also believe that most of the suspected PCAP
cases were caused by S. pneumoniae for two primary
reasons: Haemophilus influenzae type b, another
important pathogen for childhood CAP, is rela-
tively rare in Asia and Taiwan;23 and the demo-
graphic data and clinical characteristics, including
seasonality and hospitalization course, were very
similar between the suspected PCAP and likely/
definite PP groups.
In summary, this is believed to be the first
multicenter epidemiologic study of PP in children
Y.C. Huang, et al
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under 15 years of age in Taiwan. Our results indi-
cate that children hospitalized with PCAP are
common in Taiwan. About 20% of these chil-
dren need ICU admission, and some still have a
poor outcome. The data from our study may be
of interest for future studies related to CAP. We
also believe that effective immunization programs
with pneumococcal conjugate vaccine are needed
for disease control and prevention.
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